Colchicine and Post-COVID-19 Pulmonary Fibrosis
NCT04818489
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
260
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Pulmonary Fibrosis Interstitial
Interventions
DRUG:
Colchicine 0.5 MG
OTHER:
the standard protocol only
Sponsor
ClinAmygate